(Q33484423)
Statements
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3 (English)
Coombs R
Collier AC
Resnick L
Kremer AB
Pottage JC Jr
Fass RJ
Fife KH
Powderly WG
1 February 1994